Bellus Health
Why Robinhood?
You can watch Bellus Health and buy or sell other stocks, ETFs, and their options commission-free!About BLU
BELLUS Health, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937 is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch.
BLU Key Statistics
Stock Snapshot
Bellus Health(BLU) stock is priced at $14.74, giving the company a market capitalization of 1.87B. It carries a P/E multiple of -20.45.
Bellus Health(BLU) stock opened on 2026-07-09 at —. The price climbed to — and dipped to —.
The Bellus Health(BLU)'s current trading volume is 0, compared to an average daily volume of 4.95M.
In the last year, Bellus Health(BLU) shares hit a 52-week high of $14.76 and a 52-week low of $6.38.
In the last year, Bellus Health(BLU) shares hit a 52-week high of $14.76 and a 52-week low of $6.38.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.